| English Alias: |
(S)-3-((1-Methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole;3-(((2R)-1-Methyl-2-pyrrolidinyl))methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide;Relpax Also see: E505000;Eletriptan HBr;1H-Indole, 3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-, hydrobromide (1:1);Eletriptan HCl;Eletriptan hydrobromide;Relpax Also see: E50;Relpax
Also see: E505000;(R)-3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide;(R)-3-[(1-methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole hydrobromide salt;3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl) ethyl]-1H-indole hydrobromide;Eletriptan Base;Relert;Uk 116044-04;Unii-m41W832ta3;Eletriptan hydrobromide (Eletriptan HBr);1D receptor agonist;Eletriptan hydrobromide, >=98% (HPLC);3-(N-Methyl-2(R)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethly)-1H-indole hydrobromide;Relpax;177834-92-3;Eletriptan hydrobromide (JAN/USAN);UTINOWOSWSPFLJ-FSRHSHDFSA-N;eletriptan monohydrobromide;3-(N-methyl-2(R)-pyrrolidinyl methyl)-5-[2-(phenyl sulfonyl)ethyl]-1H-indole hydrobromide;3-(N-methyl-2(R)-pyrrolidinylmethyl)-5-[2-(phenyl sulfonyl)ethyl]-1H-indole hydrobromide;5-(2-(phenylsulfonyl)ethyl)-3-((2R)-pyrrolidin-2-ylmethyl)-1H-indole hydrobromide;5-[2-(phenylsulfonyl)ethyl]-3-[(2R)-pyrrolidin-2-ylmethyl]-1H-indole hydrobromide;MFCD08141806;SW220149-1;5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indol-1-ium;bromide;(R)-3-(1-Methylpyrrolidin-2-ylmethyl)-5-(2-phenylsulfonylethyl)-1H-indole monohydrobromide;ELETRIPTAN HYDROBROMIDE [MART.];Relpax (TN);CS-0379;CHEMBL1201003;D01973;J-011323;NSC-759258;DTXCID101474255;AC-3398;(r)-3-[(1-methyl-2-pyrrolidinyl) methyl]-5-[2-(phenylsulfonyl) ethyl]-1h-indole monohydrobromide;ELETRIPTAN HYDROBROMIDE (USP-RS);5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole;hydrobromide;Eletriptan Hydrobromide [USAN];3-(((R)-1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)indole, monohydrobromide;UK-116,044-04;Eletriptan (hydrobromide);C22H26N2O2S.HBr;3-[[(2R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole Hydrobromide;3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide;ELETRIPTAN HYDROBROMIDE [WHO-DD];ELETRIPTAN HYDROBROMIDE [MI];(R)-3-((1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide;1H-Indole, 3-(((2R)-1-methyl-2-pyrrolidinyl))methyl)-5-(2-(phenylsulfonyl)ethyl)-, monohydrobromide;BCP9000640;HB1775;3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole, monohydrobromide;CHEBI:61176;ELETRIPTAN HYDROBROMIDE [ORANGE BOOK];SCHEMBL317370;ELETRIPTAN HYDROBROMIDE [JAN];AKOS024262728;Tox21_500408;NCGC00261093-01;NSC 759258;M41W832TA3;ELETRIPTAN HYDROBROMIDE [USP-RS];HY-A0010;3-(N-Methyl-2(R)-pyrrolidinylmethyl)-5-(... |
3-Thiophenecarboxylic acid, 5-(4-aminophenyl)-2-[[(2,6-difluorophenyl)methyl](ethoxycarbonyl)amino]-4-[(dimethylamino)methyl]-, ethyl ester, hydrochloride
Cas No: 2768834-98-4
1-ETHYL-7-CHLORO-6-FLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID
Cas No: 68077-26-9
2-Methyl-3-tritylamino-4-(2-N-bocamino)ethylaminoacarbonylamino-2H-pyrazole
Cas No: 689293-69-4
